326 related articles for article (PubMed ID: 29205640)
21. The utility of presepsin in diagnosis and risk stratification for the emergency patients with sepsis.
Lu B; Zhang Y; Li C; Liu C; Yao Y; Su M; Shou S
Am J Emerg Med; 2018 Aug; 36(8):1341-1345. PubMed ID: 29276032
[TBL] [Abstract][Full Text] [Related]
22. Presepsin for the Diagnosis of Neonatal Early-Onset Sepsis: A Systematic Review and Meta-analysis.
Poggi C; Lucenteforte E; Petri D; De Masi S; Dani C
JAMA Pediatr; 2022 Aug; 176(8):750-758. PubMed ID: 35639395
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis.
Leli C; Ferranti M; Marrano U; Al Dhahab ZS; Bozza S; Cenci E; Mencacci A
J Med Microbiol; 2016 Aug; 65(8):713-719. PubMed ID: 27170331
[TBL] [Abstract][Full Text] [Related]
24. The Utility of Soluble CD14 Subtype in Early Diagnosis of Culture-Proven Early-Onset Neonatal Sepsis and Prediction of Outcome.
Gad GI; Shinkar DM; Kamel El-Din MM; Nagi HM
Am J Perinatol; 2020 Apr; 37(5):497-502. PubMed ID: 30900217
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy of presepsin (sCD14-ST) as a biomarker of infection and sepsis in the emergency department.
de Guadiana Romualdo LG; Torrella PE; Acebes SR; Otón MDA; Sánchez RJ; Holgado AH; Santos EJ; Freire AO
Clin Chim Acta; 2017 Jan; 464():6-11. PubMed ID: 27823951
[TBL] [Abstract][Full Text] [Related]
26. Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis.
Yoon SH; Kim EH; Kim HY; Ahn JG
BMC Infect Dis; 2019 Aug; 19(1):760. PubMed ID: 31470804
[TBL] [Abstract][Full Text] [Related]
27. Utility of cytokines to predict neonatal sepsis.
Ye Q; Du LZ; Shao WX; Shang SQ
Pediatr Res; 2017 Apr; 81(4):616-621. PubMed ID: 27997530
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study.
Endo S; Suzuki Y; Takahashi G; Shozushima T; Ishikura H; Murai A; Nishida T; Irie Y; Miura M; Iguchi H; Fukui Y; Tanaka K; Nojima T; Okamura Y
J Infect Chemother; 2012 Dec; 18(6):891-7. PubMed ID: 22692596
[TBL] [Abstract][Full Text] [Related]
29. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
[TBL] [Abstract][Full Text] [Related]
30. The Physiological Variation in Plasma Presepsin Levels During the Early Neonatal Period.
Ishii M; Hoshina T; Ichikawa S; Shimizu D; Araki S; Kinjo T; Shibata E; Hachisuga T; Kusuhara K
Tohoku J Exp Med; 2018 Nov; 246(3):199-203. PubMed ID: 30487373
[TBL] [Abstract][Full Text] [Related]
31. New Diagnostic Possibilities for Neonatal Sepsis.
Tzialla C; Manzoni P; Achille C; Bollani L; Stronati M; Borghesi A
Am J Perinatol; 2018 May; 35(6):575-577. PubMed ID: 29695000
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of presepsin as diagnostic and prognostic marker of sepsis in daily clinical practice.
Jereb M; Mavric M; Skvarc M; Drobnic A; Dolenc S; Strunjas NP; Luksic B; Kmet NG
J Infect Dev Ctries; 2019 Nov; 13(11):1038-1044. PubMed ID: 32087076
[TBL] [Abstract][Full Text] [Related]
33. Presepsin: A new marker of catheter related blood stream infections in pediatric patients.
Tanır Basaranoglu S; Karadag-Oncel E; Aykac K; Ozsurekci Y; Aycan AE; Cengiz AB; Kara A; Ceyhan M
J Infect Chemother; 2018 Jan; 24(1):25-30. PubMed ID: 28919353
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein for late-onset sepsis diagnosis in very low birth weight infants.
Beltempo M; Viel-Thériault I; Thibeault R; Julien AS; Piedboeuf B
BMC Pediatr; 2018 Jan; 18(1):16. PubMed ID: 29382319
[TBL] [Abstract][Full Text] [Related]
35. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.
Papp M; Tornai T; Vitalis Z; Tornai I; Tornai D; Dinya T; Sumegi A; Antal-Szalmas P
World J Gastroenterol; 2016 Nov; 22(41):9172-9185. PubMed ID: 27895404
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic accuracy of presepsin in predicting bacteraemia in elderly patients admitted to the emergency department: prospective study in Japan.
Imai Y; Taniguchi K; Iida R; Nitta M; Uchiyma K; Takasu A
BMJ Open; 2019 Dec; 9(12):e030421. PubMed ID: 31843822
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens.
Stoma I; Karpov I; Uss A; Rummo O; Milanovich N; Iskrov I
Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):15-21. PubMed ID: 27793578
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome.
Shozushima T; Takahashi G; Matsumoto N; Kojika M; Okamura Y; Endo S
J Infect Chemother; 2011 Dec; 17(6):764-9. PubMed ID: 21560033
[TBL] [Abstract][Full Text] [Related]
39. Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis.
van Maldeghem I; Nusman CM; Visser DH
BMC Immunol; 2019 Jun; 20(1):17. PubMed ID: 31159729
[TBL] [Abstract][Full Text] [Related]
40. Mean platelet volume in preterm: a predictor of early onset neonatal sepsis.
Shaaban HA; Safwat N
J Matern Fetal Neonatal Med; 2020 Jan; 33(2):206-211. PubMed ID: 29886794
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
